Nardo Zaias
Miami Beach, FLNPI 1952343923
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 216 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AbbVie at 35.7% of the total. Reporting peaked in 2023 at $1,144 and has fallen 89.8% since, to $117 in 2024.
Across 216 payments — averaging $22.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Novartis$517
- Journey Medical Corporation$353
- Lilly USA, LLC$312
- Johnson & Johnson$258
- Sanofi$230
- plus $1K from 18 others
Across 6 payments — averaging $4929.26 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$30K
What the payments were for
- Food & beverage$4,816100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 67 | $1,717 |
| Novartis | 24 | $517 |
| Journey Medical Corporation | 17 | $353 |
| Lilly USA, LLC | 16 | $312 |
| Johnson & Johnson | 12 | $258 |
| Sanofi | 9 | $230 |
| Regeneron Healthcare Solutions, Inc. | 8 | $184 |
| Amgen | 6 | $145 |
| Pfizer | 7 | $143 |
| Boehringer Ingelheim | 6 | $131 |
| LEO Pharma Inc. | 8 | $128 |
| Biofrontera Inc. | 7 | $114 |
| Sun Pharmaceutical Industries Inc. | 6 | $113 |
| Incyte Corporation | 5 | $108 |
| Genentech USA, Inc. | 4 | $83 |
| DUSA Pharmaceuticals, Inc. | 3 | $66 |
| E.r. Squibb & Sons, L.L.C. | 3 | $61 |
| Almirall LLC | 2 | $40 |
| Galderma Laboratories, L.p. | 1 | $24 |
| Acera Surgical, Inc. | 1 | $20 |
| Genentech, Inc. | 1 | $19 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $17 |
| Organogenesis Inc. | 1 | $17 |
| Bristol Myers Squibb | 1 | $16 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.